Lindbrook Capital’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $5.75K | Buy |
+2,195
| New | +$5.75K | ﹤0.01% | 1900 |
|
|
2024
Q3 | – | Sell |
-645
| Closed | -$4.21K | – | 2898 |
|
|
2024
Q2 | $4.21K | Buy |
645
+304
| +89% | +$1.98K | ﹤0.01% | 2081 |
|
|
2024
Q1 | $2.83K | Sell |
341
-106
| -24% | -$880 | ﹤0.01% | 2121 |
|
|
2023
Q4 | $4.92K | Buy |
447
+232
| +108% | +$2.55K | ﹤0.01% | 1898 |
|
|
2023
Q3 | $1.81K | Buy |
215
+65
| +43% | +$547 | ﹤0.01% | 2164 |
|
|
2023
Q2 | $1.88K | Buy |
150
+22
| +17% | +$276 | ﹤0.01% | 2169 |
|
|
2023
Q1 | $2.11K | Buy |
128
+116
| +967% | +$1.91K | ﹤0.01% | 2225 |
|
|
2022
Q4 | $179 | Sell |
12
-253
| -95% | -$3.77K | ﹤0.01% | 2741 |
|
|
2022
Q3 | $6K | Buy |
265
+147
| +125% | +$3.33K | ﹤0.01% | 1588 |
|
|
2022
Q2 | $2K | Buy |
118
+16
| +16% | +$271 | ﹤0.01% | 2040 |
|
|
2022
Q1 | $3K | Buy |
+102
| New | +$3K | ﹤0.01% | 1868 |
|